The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
D’Onofrio, M., Cuomo, L., Battaglia, G., Ngomba, R. T., Storto, M., Kingston, A. E., Orzi, F., Blasi, A. D., Iorio, P. D., Nicoletti, F., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00435.x · Cited by 126
Self-citationRetractedKessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“significant disability (Murray and Lopez, 1997) and with excess mortality (Cuijpers and Smit, 2002) particularly from cardiovascular disease (Rivelli and Jiang, 2007).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 1×
“ficking and activity-dependent release of BDNF (Egan et al., 2003), and an increased risk to develop treatment-resistant depression”
BackgroundA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
Causal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“, 2003) independently from COX inhibition (Weggen et al., 2001; Rojo et al., 2008).”
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Untreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · cited 1×
“Recently, BDNF gene delivery has also been found to exert substantial protective effects in Alzheimer's disease models and has been proposed as a new potential therapy for Alzheimer's disease (Nagahara et al., 2009).”
BackgroundGlutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease
HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · cited 2×
“An impairment of BDNF signalling has been demonstrated also in Alzheimer's disease (Murer et al., 2001; Cotman, 2005).”
BackgroundGoodman, Y., Bruce, A. J., Cheng, B., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66051836.x · Cited by 830
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Excess mortality in depression: a meta-analysis of community studies
Cuijpers, P., & Smit, F. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00413-x · Cited by 775
A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults
Castaneda, A. E., Tuulio-Henriksson, A., Marttunen, M., Suvisaari, J., & Lönnqvist, J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.06.006 · Cited by 752
Glucocorticoids increase amyloid-β and tau pathology in a mouse model of alzheimer’s disease
Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L., & LaFerla, F. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2797-06.2006 · Cited by 623
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Depression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 612
Fava, M., & Kendler, K. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00112-4 · Cited by 603
Karege, F., Vaudan, G., Schwald, M., Perroud, N., & La Harpe, R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.020 · Cited by 600 · cited 1×
“Kessing and Andersen (2004) have demonstrated that the risk to develop Alzheimer's disease increases with every new affective episode associated to mood disorders (Kessing, 1998; Kessing and Andersen, 2004).”
BackgroundStress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Comparison of stressors
Magarin˜os, A. M., & McEwen, B. S. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00256-i · Cited by 571
Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564
BDNF in schizophrenia, depression and corresponding animal models
Angelucci, F., Brenè, S., & Mathé, A. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001637 · Cited by 548
The stress system in depression and neurodegeneration: Focus on the human hypothalamus
Bao, A.-M., Meynen, G., & Swaab, D. F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.005 · Cited by 548
Modrego, P. J., & Ferrández, J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1290 · Cited by 537
A randomized controlled trial of prednisone in Alzheimer’s disease
Aisen, P. S., Davis, K. L., Berg, J. D., Schafer, K., Campbell, K., Thomas, R. G., Weiner, M. F., Farlow, M. R., Sano, M., Grundman, M., et al. (2000) · Neurology · doi:10.1212/wnl.54.3.588 · Cited by 464
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Charney, D. S., & Manji, H. K. (2004) · Science's STKE · doi:10.1126/stke.2252004re5 · Cited by 429
Sheline, Y. I., Barch, D. M., Garcia, K., Gersing, K., Pieper, C., Welsh-Bohmer, K., Steffens, D. C., & Doraiswamy, P. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.019 · Cited by 421
Czéh, B., & Lucassen, P. J. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0728-0 · Cited by 419
Kessing, L. V. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.031773 · Cited by 406
Is it time to reassess the BDNF hypothesis of depression?
Groves, J. O. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002075 · Cited by 404
Caricasole, A., Copani, A., Caraci, F., Aronica, E., Rozemuller, A. J., Caruso, A., Storto, M., Gaviraghi, G., Terstappen, G. C., & Nicoletti, F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1381-04.2004 · Cited by 398
Self-citationA randomized controlled trial of prednisone in Alzheimer’s disease
Koch, H. J., & Szecsey, A. (2000) · Neurology · doi:10.1212/wnl.55.7.1067 · Cited by 384
van Praag, H. M. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.031 · Cited by 377
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371 · cited 3×
“On the other hand, reduced levels of anti-inflammatory cytokines, such as interleukin-4 (IL-4), interleukin-10 (IL-10) and Transforming-GrowthFactor-β1 (TGF-β1), have been found in the plasma of depressed patients (Maes, 1999; Maes et al., 2009; Myint et al., 2005).”
BackgroundMethodLithium and risk for Alzheimer's disease in elderly patients with bipolar disorder
Nunes, P. V., Forlenza, O. V., & Gattaz, W. F. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.029868 · Cited by 368
Microglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367
Therapeutic approaches to Alzheimer's disease
Klafki, H.-W., Staufenbiel, M., Kornhuber, J., & Wiltfang, J. (2006) · Brain · doi:10.1093/brain/awl280 · Cited by 362
Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology
Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., Lin, A. H., Crews, L., Tremblay, P., Mathews, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27341 · Cited by 355
Geerlings, M. I., Bouter, L. M., Schoevers, R. A., Beekman, A. T. F., Jonker, C., Deeg, D. J. H., Van Tilburg, W., Adèr, H. J., & Schmand, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.6.568 · Cited by 352
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351
Inflammation, Depression and Dementia: Are they Connected?
Leonard, B. E. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9385-y · Cited by 342
Major and minor depression in Alzheimer's disease: prevalence and impact
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.4.556 · Cited by 320
An open label trial of C-1073 (mifepristone) for psychotic major depression*
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320
Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315
McLaughlin, K. J., Gomez, J. L., Baran, S. E., & Conrad, C. D. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.042 · Cited by 314
Belanoff, J. K., Gross, K., Yager, A., & Schatzberg, A. F. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00018-8 · Cited by 310
Cognitive impairment in the euthymic phase of affective disorder
KESSING, L. V. (1998) · Psychological Medicine · doi:10.1017/s0033291798006862 · Cited by 291
Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death
Herrup, K., Neve, R., Ackerman, S. L., & Copani, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3347-04.2004 · Cited by 287
Self-citationGlucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels
Sapolsky, R. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02240.1986 · Cited by 284
Rapid Reversal of Psychotic Depression Using Mifepristone
Belanoff, J. K., Flores, B. H., Kalezhan, M., Sund, B., & Schatzberg, A. F. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00009 · Cited by 282
Weggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Ozols, V., Fauq, A., Golde, T. E., & Koo, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303592200 · Cited by 280
The Construct of Minor and Major Depression in Alzheimer’s Disease
Starkstein, S. E., Jorge, R., Mizrahi, R., & Robinson, R. G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2086 · Cited by 271
Chronic Psychological Distress and Risk of Alzheimer’s Disease in Old Age
Wilson, R. S., Arnold, S. E., Schneider, J. A., Kelly, J. F., Tang, Y., & Bennett, D. A. (2006) · Neuroepidemiology · doi:10.1159/000095761 · Cited by 266 · cited 1×
“, 1999; van Praag, 2004; Charney and Manji, 2004; Pariante, 2003), and that elderly individuals prone to psychological distress are more likely to develop dementia than age-matched nonstressed individuals (Wilson et al., 2006; Simard et al., 2009).”
BackgroundBruno, V., Battaglia, G., Casabona, G., Copani, A., Caciagli, F., & Nicoletti, F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09594.1998 · Cited by 263
Self-citationThe Role of Neuroimmunomodulation in Alzheimer's Disease
Maccioni, R. B., Rojo, L. E., Fernández, J. A., & Kuljis, R. O. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03972.x · Cited by 260
Cortisol and Alzheimer's disease, I: Basal studies
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.3.300 · Cited by 246
Mitotic signaling by β‐amyloid causes neuronal death
COPANI, A., CONDORELLI, F., CARUSO, A., VANCHERI, C., SALA, A., STELLA, A. M. G., CANONICO, P. L., NICOLETTI, F., & SORTINO, M. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2225 · Cited by 245
Self-citationDepression, Stress and the Adrenal axis
(2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.01058.x · Cited by 242
Giovanni, A., Wirtz-Brugger, F., Keramaris, E., Slack, R., & Park, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19011 · Cited by 240
Mendlewicz, J., Kriwin, P., Oswald, P., Souery, D., Alboni, S., & Brunello, N. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00005 · Cited by 229
Hippocampal Morphology and Distinguishing Late-Onset From Early-Onset Elderly Depression
Ballmaier, M., Narr, K. L., Toga, A. W., Elderkin-Thompson, V., Thompson, P. M., Hamilton, L., Haroon, E., Pham, D., Heinz, A., & Kumar, A. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030506 · Cited by 226
Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction
Tong, L., Balazs, R., Soiampornkul, R., Thangnipon, W., & Cotman, C. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.027 · Cited by 222 · cited 1×
“Pro-inflammatory cytokines, such as IL-1β, render neurons vulnerable to degeneration by interfering with BDNF-induced neuroprotection (Tong et al., 2008).”
BackgroundGlucocorticoids Enhance Oxidative Stress-Induced Cell Death in Hippocampal Neurons in Vitro
Behl, C. (1997) · Endocrinology · doi:10.1210/en.138.1.101 · Cited by 220
Aharoni, R., Eilam, R., Domev, H., Labunskay, G., Sela, M., & Arnon, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509438102 · Cited by 212
Crochemore, C., Lu, J., Wu, Y., Liposits, Z., Sousa, N., Holsboer, F., & Almeida, O. F. X. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001679 · Cited by 211
Psychiatric Epidemiology: It’s Not Just About Counting Anymore
Insel, T. R., & Fenton, W. S. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.590 · Cited by 198
β-Amyloid impairs axonal BDNF retrograde trafficking
Poon, W. W., Blurton-Jones, M., Tu, C. H., Feinberg, L. M., Chabrier, M. A., Harris, J. W., Jeon, N. L., & Cotman, C. W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.012 · Cited by 198
Antidepressant action: to the nucleus and beyond
Malberg, J. E., & Blendy, J. A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.005 · Cited by 193
Neuropsychiatric symptoms in dementia: Importance and treatment considerations
Ballard, C. G., Day, S., Sharp, S. I., Wing, G., & Sorensen, S. (2008) · International Review of Psychiatry · doi:10.1080/09540260802099968 · Cited by 179
Increased Neurofibrillary Tangles in Patients With Alzheimer Disease With Comorbid Depression
Rapp, M. A., Schnaider-Beeri, M., Purohit, D. P., Perl, D. P., Haroutunian, V., & Sano, M. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31816029ec · Cited by 178
Neuropsychiatric symptoms in the dementias
Assal, F., & Cummings, J. L. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00007 · Cited by 178
Neuropsychological deficits among patients with late-onset minor and major depression
ELDERKINTHOMPSON, V, KUMAR, A., BILKER, W., DUNKIN, J., MINTZ, J., MOBERG, P., MESHOLAM, R., & GUR, R. (2003) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(03)00022-2 · Cited by 170
Copani, A., Bruno, V, Battaglia, G., Leanza, G., Pellitteri, R., Russo, A., Stanzani, S., & Nicoletti, F. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08600-6 · Cited by 167
Self-citationA New Glucocorticoid Hypothesis of Brain Aging: Implications for Alzheimers Disease
Landfield, P. W., Blalock, E. M., Chen, K.-C., & Porter, N. M. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362083 · Cited by 165
Raised levels of plasma interleukin‐1β in major and postviral depression
Owen, B. M., Eccleston, D., Ferrier, I. N., & Young, H. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00162.x · Cited by 165
Circulating cytokines in Alzheimer's disease
Singh, V. K., & Guthikonda, P. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00023-x · Cited by 163
Anti-inflammatory Drugs Protect Against Alzheimer Disease at Low Doses
Broe, G. A., Grayson, D. A., Creasey, H. M., Waite, L. M., Casey, B. J., Bennett, H. P., Brooks, W. S., & Halliday, G. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.11.1586 · Cited by 160
The pattern and course of cognitive impairment in late-life depression
Köhler, S., Thomas, A. J., Barnett, N. A., & O'Brien, J. T. (2009) · Psychological Medicine · doi:10.1017/s0033291709990833 · Cited by 159
Increase of BDNF Serum Concentration in Lithium Treated Patients with Early Alzheimer's Disease
Leyhe, T., Eschweiler, G. W., Stransky, E., Gasser, T., Annas, P., Basun, H., & Laske, C. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1004 · Cited by 158
Depression and cognition in older adults
Thomas, A. J., & O'Brien, J. T. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f2139b · Cited by 156
The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150
GREENWALD, B. S., Mathé, A. A., Mohs, R. C., Levy, M. I., Johns, C. A., & Davis, K. L. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.4.442 · Cited by 150
Transforming growth factor-β signalling in brain disorders
Vivien, D., & Ali, C. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.011 · Cited by 149
Cacabelos, R., Barquero, M. S., Garcia, P. E., Alvarez, X. A., & de Seijas, E. V. (1991) · PubMed · Cited by 148
Swanwick, G., Kirby, M., Bruce, I., Buggy, F., Coen, R. F., Coakley, D., & LAWLOR, B. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.286 · Cited by 137
Xiang, Z., Ho, L., Yemul, S., Zhao, Z., Pompl, P. N., Kelley, K. A., Dang, A., Qing, W., Teplow, D. B., & Pasinetti, G. M. (2002) · Gene Expression · doi:10.3727/000000002783992352 · Cited by 133
Stress and glucocorticoid footprints in the brain—The path from depression to Alzheimer's disease
Sotiropoulos, I., Cerqueira, J., Catania, C., Takashima, A., Sousa, N., & Almeida, O. F. X. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.007 · Cited by 120
Memory impairment in patients with late-onset major depression: The effect of antidepressant therapy
Gallassi, R., Di Sarro, R., Morreale, A., & Amore, M. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.018 · Cited by 118 · cited 1×
“Late-life depression patients frequently exhibit a significant cognitive impairment (Gallassi et al., 2006).”
BackgroundAn update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease
Imbimbo, B. P. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903066780 · Cited by 114
Kessing, L. V., Søndergård, L., Forman, J. L., & Andersen, P. K. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.020 · Cited by 113
Brunello, N., Alboni, S., Capone, G., Benatti, C., Blom, J. M. C., Tascedda, F., Kriwin, P., & Mendlewicz, J. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00004 · Cited by 113
Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression
Anttila, S., Huuhka, K., Huuhka, M., Rontu, R., Hurme, M., Leinonen, E. V. J., & Lehtimäki, T. J. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0705-9 · Cited by 112
Structure-Function Implications in Alzheimers Disease: Effect of Aβ Oligomers at Central Synapses
Cerpa, W. F., Dinamarca, M. C., & Inestrosa, N. C. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533321 · Cited by 100
Corticosterone Enhances Kainic Acid‐Induced Calcium Elevation in Cultured Hippocampal Neurons
Elliott, E. M., & Sapolsky, R. M. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08345.x · Cited by 96
Neuronal actions of glucocorticoids: Focus on depression
Yu, S., Holsboer, F., & Almeida, O. F. X. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.014 · Cited by 90
Pasinetti, G. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4510 · Cited by 89
Ábrahám, I. M., Harkany, T., Horvath, K. M., Veenema, A. H., Penke, B., Nyakas, C. J., & Luiten, P. G. M. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00475.x · Cited by 86
TGF-β Pathway as a Potential Target in Neurodegeneration and Alzheimers
Wyss-Coray, T. (2006) · Current Alzheimer Research · doi:10.2174/156720506777632916 · Cited by 85
Age-related cognitive decline in patients with mood disorders
Gualtieri, C. T., & Johnson, L. G. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.12.030 · Cited by 80
TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway
Caraci, F., Battaglia, G., Busceti, C., Biagioni, F., Mastroiacovo, F., Bosco, P., Drago, F., Nicoletti, F., Sortino, M. A., & Copani, A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.007 · Cited by 79
Self-citationMocali, A., Cedrola, S., Malva, N. D., Bontempelli, M., Costanza, V. A. M., Bavazzano, A., Comolli, R., Paoletti, F., & Porta, C. A. M. L. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.07.007 · Cited by 79
Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model
Vollmar, P., Haghikia, A., Dermietzel, R., & Faustmann, P. M. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007729 · Cited by 75
Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression
Borroni, B., Archetti, S., Costanzi, C., Grassi, M., FERRARI, M. M. H., Radeghieri, A., Caimi, L., Caltagirone, C., Luca, M. D., & Padovani, A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.023 · Cited by 73
Carlson, L. E., Sherwin, B. B., & Chertkow, H. M. (1999) · Hormones and Behavior · doi:10.1006/hbeh.1999.1518 · Cited by 71
Nutrition, growth, and development
Tizard, J. (1976) · Psychological Medicine · doi:10.1017/s003329170000742x · Cited by 70
Sometani, A., Kataoka, H., Nitta, A., Fukumitsu, H., Nomoto, H., & Furukawa, S. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1229 · Cited by 70
Glucocorticoid antagonists in neuropsychotic disorders
Schatzberg, A. F., & Lindley, S. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.001 · Cited by 68
Neurofibrillary Tangles May Interfere With Smad 2/3 Signaling in Neurons
Chalmers, K. A., & Love, S. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180303b93 · Cited by 68
The Role of Neurotrophins in Brain Aging: A Perspective in Honor of Regino Perez-Polo
Cotman, C. W. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6960-y · Cited by 66
Walz, J. C., Frey, B. N., Andreazza, A. C., Ceresér, K. M. M., de Cacilhas, A. A., Valvassori, S. S., Quevedo, J., & Kapczinski, F. P. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.03.005 · Cited by 65
Synaptotoxicity in Alzheimer's Disease: The Wnt Signaling Pathway as a Molecular Target
Inestrosa, N. C., Varela‐Nallar, L., Grabowski, C. P., & Colombres, M. (2007) · IUBMB Life · doi:10.1080/15216540701242490 · Cited by 65
IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease
Huberman, M., Sredni, B., Stern, L., Kott, E., & Shalit, F. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00016-u · Cited by 62 · cited 1×
“, 1991) and augmented plasma levels of IL-6 (Huberman et al., 1995; Singh and Guthikonda, 1997) have been found”
BackgroundPsychological distress and risk for dementia
Simard, M., Hudon, C., & van Reekum, R. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0007-z · Cited by 62
Blasey, C. M., DeBattista, C., Roe, R., Block, T., & Belanoff, J. K. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.03.001 · Cited by 61
Prognosis of late life depression: a three‐year cohort study of outcome and potential predictors
Baldwin, R., Gallagley, A., Gourlay, M., Jackson, A., & Burns, A. S. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1424 · Cited by 61
Inflammatory Aspects of Depression
Adler, U. C., Marques, A., & Calil, H. M. (2008) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152808784165216 · Cited by 61
Copani, A., Caraci, F., Hoozemans, J. J. M., Calafiore, M., Sortino, M. A., & Nicoletti, F. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.016 · Cited by 55
Self-citationA predictive depression pattern in mild cognitive impairment
Houde, M., Bergman, H., Whitehead, V., & Chertkow, H. M. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2028 · Cited by 55
Mifepristone (RU 486) for Alzheimer’s disease
Pomara, N., Doraiswamy, P. M., Tun, H., & Ferris, S. H. (2002) · Neurology · doi:10.1212/wnl.58.9.1436 · Cited by 52
Dhikav, V., & Anand, K. S. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.038 · Cited by 50
Cortisol and Alzheimer's Disease
Davous, P. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.4.aj1444533 · Cited by 48
High plasma levels of cortisol in patients with senile dementia of the Alzheimer's type.
Masugi, F., Ogihara, T., Sakaguchi, K., Otsuka, A., Tsuchiya, Y., Morimoto, S., Kumahara, Y., Saeki, S., & Nishide, M. (1989) · PubMed · Cited by 48
Neurotrophic Factors in Neurodegenerative Disorders: Potential for Therapy
Fumagalli, F., Molteni, R., Calabrese, F., Maj, P. F., Racagni, G., & Riva, M. A. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00004 · Cited by 46
Depression and ischemic heart disease: what have we learned from clinical trials?
Rivelli, S. K., & Jiang, W. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3281ead011 · Cited by 42
Matrisciano, F., Panaccione, I., Zusso, M., Giusti, P., Tatarelli, R., Iacovelli, L., Mathé, A. A., Gruber, S. H. M., Nicoletti, F., & Girardi, P. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002005 · Cited by 42
Self-citationArosio, B., Bergamaschini, L. C., Galimberti, L., Porta, C. A. M. L., Zanetti, M., Calabresi, C., Scarpini, E. A., Annoni, G., & Vergani, C. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.07.006 · Cited by 38
HPA axis responsivity to dexamethasone and cognitive impairment in dementia
Gurevich, D., Siegel, B. V., Dumlao, M., Perl, E., Chaitin, P., Bagne, C. A., & Oxenkrug, G. F. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90018-c · Cited by 37
MILWAIN, E., & Nagy, Z. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080971 · Cited by 32
Tsai, S. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.051 · Cited by 29
Depression as prognostic factor: 6 months follow-up in a geriatric institution
Shim, Y. S., & Yang, D. (2006) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2005.11.002 · Cited by 29
Yeh, H., & Tsai, S. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.03.049 · Cited by 28
C-1073 (Mifepristone) in the Adjunctive Treatment of Alzheimers Disease
DeBattista, C., & Belanoff, J. K. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585954 · Cited by 25
Robert, P., Schück, S., Dubois, B., Lépine, J. P., Gallarda, T., Olié, J.-P., Goni, S., & Troy, S. (2003) · PubMed · Cited by 20
Cited by
Behavioral and psychological symptoms of dementia
Cerejeira, J., Lagarto, L., & Mukaetova-Ladinska, E. B. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00073 · Cited by 1,425
Depression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265
MacQueen, G., & Frodl, T. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.80 · Cited by 665
Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096905 · Cited by 449
Self-citationGomez‐Pinilla, F., Zhuang, Y., Feng, J., Ying, Z., & Fan, G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07508.x · Cited by 367
Metadata
- Authors
- Caraci, F., Copani, A., Nicoletti, F., & Drago, F.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 626
- Issue
- 1
- Pages
- 64-71
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2022637707
- Cited by
- 314
- References
- 146
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.